Lysozyme is used in biochemical research; clinically for the treatment of acute and chronic pharyngitis, lichen planus, and verruca plana; as a preservative and antimicrobial agent in food industries (especially in cheese and sake production); in pharmaceutical formulations (tablets, capsules, eye drops, throat lozenges); in cosmetics and oral care products (e.g., toothpaste); in infant formula (humanized milk powder); for yeast recovery and propagation in beer production without affecting yeast; to prevent bacterial contamination during early fermentation stages; in seafood and meat products for preservation and extension of shelf life, especially when combined with sodium chloride and nitrites; in dairy and baked goods (e.g., cream cakes) to prevent microbial spoilage; as a tool enzyme in biotechnology for preparing protoplasts from Gram-positive bacteria by degrading peptidoglycan in cell walls, facilitating genetic and cell engineering; in medical applications for treating mucosal inflammations (e.g., sinusitis, chronic rhinitis, stomatitis, otitis media), dermatological conditions (e.g., herpes zoster, verruca plana, varicella), and other diseases such as asthmatic bronchitis, ulcerative colitis, and mumps; and exhibits antiviral activity by binding to negatively charged viral proteins and forming insoluble complexes with DNA, RNA, or apoproteins, thereby inactivating viruses.